Genetic Variability of Hepatitis C Virus before and after Combined Therapy
Author Information
Author(s): José Manuel Cuevas, Manuela Torres-Puente, Nuria Jiménez-Hernández, María Alma Bracho, Inmaculada García-Robles, Boris Wrobel, Fernando Carnicer, Juan del Olmo, Enrique Ortega, Andrés Moya, Fernando González-Candelas
Primary Institution: Instituto Cavanilles de Biodiversidad y Biología Evolutiva and Departamento de Genética, Universidad de Valencia, Valencia, Spain
Hypothesis
What are the selective forces acting on hepatitis C virus genome regions involved in the viral response to combined antiviral therapy?
Conclusion
The study found that there is no common adaptive mechanism for the lack of response to antiviral treatment in hepatitis C virus patients, indicating a wide range of evolutionary strategies used by the virus.
Supporting Evidence
- The study sequenced 4690 E1-E2 region clones and 2486 NS5A region clones from the patients.
- Significant differences in nucleotide diversity were detected in most cases using t-tests.
- Phylogenetic trees showed a wide range of evolutionary patterns among patients.
Takeaway
This study looked at how the hepatitis C virus changes when patients don't respond to treatment, finding that each patient's virus behaves differently.
Methodology
The study analyzed samples from 22 non-responder patients before and after treatment, sequencing a range of clones to detect patterns of adaptation.
Potential Biases
Potential biases may arise from the selection of patients who did not respond to treatment, limiting the generalizability of the findings.
Limitations
The study focused only on non-responder patients, which may not represent the broader population of hepatitis C patients.
Participant Demographics
Patients included 7 infected with subtype 1a and 15 with subtype 1b.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website